Trials / Conditions / Primary Immune Deficiency Disorder

Primary Immune Deficiency Disorder

26 registered clinical trials studyying Primary Immune Deficiency Disorder — 5 currently recruiting.

Status	Trial	Sponsor	Phase
Active Not Recruiting	Observational Study of Subcutaneous Immunoglobulin (Cutaquig) in Patients With Primary and Secondary Immunodef NCT04354129	University of Alberta	—
Recruiting	EBV-specific Cytotoxic T-lymphocytes (CTLs) for Refractory EBV Infection NCT03266653	New York Medical College	Phase 2
Recruiting	Treatment of Refractory BK Infections With Related Donor BK Specific Cytotoxic T-cells (CTLs) NCT04197596	New York Medical College	Phase 1 / Phase 2
Unknown	Coronavirus (COVID-19) Outcomes Registries in Immunocompromised Individuals Australia (CORIA) NCT04354818	Kirby Institute	—
Recruiting	Regenerative Medicine to Restore Hematopoiesis and Immune Function in Immunodeficiencies and Inherited Bone Ma NCT04232085	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins	Phase 2
Completed	Study to Monitor Subcutaneous Human Immunoglobulin Administered at Modified Dosing Regimens in Patients With P NCT03939533	Octapharma	Phase 3
Withdrawn	Study of Immune Globulin Intravenous (Human) GC5101F in Subjects With Primary Humoral Immunodeficiency NCT03492710	Green Cross Corporation	Phase 3
Recruiting	Virus Specific Cytotoxic T-Lymphocytes (CTLs) for Refractory Cytomegalovirus (CMV) NCT03266640	New York Medical College	Phase 2
Recruiting	Adenovirus-specific Cytotoxic T-lymphocytes for Refractory Adenovirus Infection NCT03266627	New York Medical College	Phase 2
Completed	Primary Immunodeficiency in Kuwait NCT03618147	Kuwait Society for Allergy and Clinical Immunology	—
Completed	The Impact of Exercise on Stress, Fatigue, and Quality of Life in Individuals With Primary Immunodeficiency Di NCT03211689	Stockton University	N/A
Unknown	Immunological Characteristics of Patients With PID and IBD NCT03148028	Sheba Medical Center	—
Completed	Study to Evaluate the Efficacy, Tolerability and Safety of Octanorm in Patients With Primary Immunodeficiency NCT03988426	Octapharma	Phase 3
Unknown	A Study About Low Blood Pressure in Patients With Primary Immunodeficiency Disease Treated With Immune Globuli NCT03037359	ADMA Biologics, Inc.	—
Completed	Investigation of Dental Health in Children With Neutrophil Defects: A Clinical Study NCT03069079	Queen Mary University of London	N/A
Unknown	Identification of New Inborn Errors of Immunity NCT03414528	University of Zurich	—
Unknown	Pathophysiology of Inborn Immunodeficiencies NCT03422614	University of Zurich	—
Completed	Intensive Care Unit and Secondary and Primary Immune Deficiency NCT02888535	University Hospital, Caen	—
Active Not Recruiting	Study of Gene Modified Donor T-cells Following TCR Alpha Beta Positive Depleted Stem Cell Transplant NCT03301168	Bellicum Pharmaceuticals	Phase 1 / Phase 2
Completed	Study of Octanorm Subcutaneous IG in Patients With PID NCT01888484	Octapharma	Phase 3
Completed	Pharmacokinetics, Efficacy, and Safety Study of RI-002 (IGIV) in Subjects With Primary Immunodeficiency Diseas NCT01814800	ADMA Biologics, Inc.	Phase 3
Terminated	Gamma Globulin Observations and Outcomes Database for Patients With Primary Immunodeficiency Disease (GOOD-SHE NCT01883921	BriovaRx Infusion Services	—
Completed	Octagam 5% Versus Comparator Post Marketing Trial NCT01859754	Octapharma	—
Completed	TCR Alpha/Beta Depletion for HSCT From Haploidentical and Unrelated Donors in the Treatment of PID NCT02327351	Federal Research Institute of Pediatric Hematology, Oncology and Immunology	Phase 2 / Phase 3
Completed	Follow-up Study of Subcutaneous Immune Globulin in Patients Requiring IgG Replacement Therapy (Japan Study) NCT01458171	CSL Behring	Phase 3
Completed	Study of Vitamin D3 Substitution to Patients With Primary Immunodeficiency NCT01131858	Karolinska University Hospital	Phase 1 / Phase 2